Immediate Impact
1 from Science/Nature 53 standout
Citing Papers
Targeted protein degradation: from mechanisms to clinic
2024 Standout
The mechanism of ferroptosis and its related diseases
2023 Standout
Works of D. Vassilief being referenced
Does iron chelation therapy improve survival in regularly transfused lower risk MDS patients? A multicenter study by the GFM
2010
A non‐randomised dose‐escalating phase II study of thalidomide for the treatment of patients with low‐risk myelodysplastic syndromes: the Thal‐SMD‐2000 trial of the Groupe Français des Myélodysplasies
2005
Author Peers
| Author | Last Decade | Papers | Cites | ||||
|---|---|---|---|---|---|---|---|
| D. Vassilief | 258 | 187 | 8 | 42 | 11 | 288 | |
| M. M. K. Shing | 114 | 63 | 12 | 18 | 12 | 275 | |
| M Robson | 74 | 88 | 16 | 41 | 10 | 259 | |
| Usha Sitaram | 144 | 50 | 1 | 51 | 15 | 271 | |
| Elisa Cerqui | 197 | 80 | 20 | 90 | 18 | 278 | |
| J. Greher | 251 | 38 | 3 | 58 | 9 | 335 | |
| Momodou W. Jallow | 188 | 120 | 25 | 10 | 13 | 242 | |
| Mariagiovanna Cefalo | 92 | 49 | 2 | 62 | 11 | 229 | |
| F D'Adamo | 196 | 110 | 3 | 126 | 11 | 310 | |
| M Kuentz | 183 | 80 | 1 | 18 | 13 | 256 | |
| Veronika Válková | 221 | 44 | 68 | 13 | 275 |
All Works
Loading papers...